On 1 April 2014, Remicade® (infliximab) was made available on the Pharmaceutical Benefits Scheme (PBS) in limited circumstances for patients with acute severe ulcerative colitis. The PBS listing of the biologic medicine provides Australians who are experiencing a sudden severe flare-up of ulcerative colitis (otherwise known as acute severe ulcerative colitis) with a new medical … Continue reading Remicade on PBS for severe colitis